ABWYX
Price
$15.61
Change
-$0.00 (-0.00%)
Updated
May 23 closing price
Net Assets
411.81M
RLBGX
Price
$34.89
Change
-$0.05 (-0.14%)
Updated
May 23 closing price
Net Assets
237.88B
Interact to see
Advertisement

ABWYX vs RLBGX

Header iconABWYX vs RLBGX Comparison
Open Charts ABWYX vs RLBGXBanner chart's image
AB All Market Total Return Advisor
Price$15.61
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets411.81M
American Funds American Balanced R6
Price$34.89
Change-$0.05 (-0.14%)
VolumeN/A
Net Assets237.88B
ABWYX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABWYX vs. RLBGX commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABWYX is a Buy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 238B vs. ABWYX (412M). ABWYX pays higher dividends than RLBGX: ABWYX (3.33) vs RLBGX (2.31). ABWYX was incepted earlier than RLBGX: ABWYX (22 years) vs RLBGX (16 years). ABWYX (0.85) is less costly to investors than RLBGX (0.25). ABWYX is a more actively managed with annual turnover of: 182.00 vs. RLBGX (44.00). ABWYX has a lower initial minimum investment than RLBGX: ABWYX (0) vs RLBGX (250). ABWYX annual gain was more profitable for investors over the last year : 8.23 vs. RLBGX (5.61). RLBGX return over 5 years is better than : 39.90 vs. ABWYX (24.28).
ABWYXRLBGXABWYX / RLBGX
Total Expense Ratio0.840.25336%
Annual Report Gross Expense Ratio0.850.25340%
Fund Existence22 years16 years-
Gain YTD3.1731.973161%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets412M238B0%
Annual Yield % from dividends3.332.31144%
Returns for 1 year8.235.61147%
Returns for 3 years17.2023.2274%
Returns for 5 years24.2839.9061%
Returns for 10 years30.1255.9754%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGX203.2610.13
+5.25%
Argan
WES38.940.45
+1.17%
Western Midstream Partners LP
INDP0.37-0.01
-2.89%
Indaptus Therapeutics
RCKT6.27-0.32
-4.86%
Rocket Pharmaceuticals
BDSX0.34-0.05
-13.29%
Biodesix